NCT00095082 · Interventional trial
Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes
Overall registry status Completed
Phase 3
Conditions Diabetes, Diabetes Mellitus, Type 1
Delaware Valley sites
- Novo Nordisk Investigational Site · Berlin, NJ · Camden County
- Novo Nordisk Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory